Diabetes, Vol 39, Issue 12 1490-1497, Copyright © 1990 by American Diabetes Association

ARTICLES

Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney

H Werner, Z Shen-Orr, B Stannard, B Burguera, CT Roberts and D LeRoith
Diabetes Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Insulinlike growth factor I (IGF-I) is a mitogenic hormone with important regulatory roles in growth and development. One of the target organs for IGF-I action is the kidney, which synthesizes abundant IGF-I receptors and IGF-I itself. To study the involvement of IGF-I and the IGF-I receptor in the development of nephropathy, one of the major complications of diabetes mellitus, we measured the expression of these genes in the kidney and in other tissues of the streptozocin-induced diabetic rat. The binding of 125I-labeled IGF-I to crude membranes was measured in the same tissues. We observed a 2.5-fold increase in the steady-state level of IGF-I-receptor mRNA in the diabetic kidney, which was accompanied by a 2.3-fold increase in IGF-I binding. In addition to this increase in IGF-I binding to the IGF-I receptor, there was also binding to a lower-molecular-weight material that may represent an IGF-binding protein. No change was detected in the level of IGF-I-peptide mRNA. Similarly, IGF-II-receptor mRNA levels and IGF-II binding were significantly increased in the diabetic kidney. IGF-I- and IGF-II-receptor mRNA levels and IGF-I and IGF-II binding returned to control values after insulin treatment. Because the IGF-I receptor is able to transduce mitogenic signals on activation of its tyrosine kinase domain, we hypothesize that, among other factors, high levels of receptor in the diabetic kidney may also be involved in the development of diabetic nephropathy. Increased IGF-II-receptor expression in the diabetic kidney may be important for the intracellular transport and packaging of lysosomal enzymes, although a role for this receptor in signal transduction cannot be excluded. Finally, the possible role of IGF-binding proteins requires further study.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Karl, M. Potier, I. H. Schulman, A. Rivera, H. Werner, A. Fornoni, and S. J. Elliot Autocrine Activation of the Local Insulin-Like Growth Factor I System Is Up-Regulated by Estrogen Receptor (ER)-Independent Estrogen Actions and Accounts for Decreased ER Expression in Type 2 Diabetic Mesangial Cells Endocrinology, February 1, 2005; 146(2): 889 - 900. [Abstract] [Full Text] [PDF]

				B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]

				E. Cellier, M. Mage, J. Duchene, C. Pecher, R. Couture, J.-L. Bascands, and J.-P. Girolami Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F282 - F292. [Abstract] [Full Text] [PDF]

				P. H. Lane Diabetic kidney disease: impact of puberty Am J Physiol Renal Physiol, October 1, 2002; 283(4): F589 - F600. [Abstract] [Full Text] [PDF]

				K. Amri, N. Freund, J.P. D. Van Huyen, C. Merlet-Bénichou, and M. Lelièvre-Pégorier Altered Nephrogenesis Due to Maternal Diabetes Is Associated With Increased Expression of IGF-II/Mannose-6-Phosphate Receptor in the Fetal Kidney Diabetes, May 1, 2001; 50(5): 1069 - 1075. [Abstract] [Full Text]

				A. De la Puente, L. Goya, S. Ramos, M. A. Martin, C. Alvarez, F. Escriva, and A. M. Pascual-Leone Effects of experimental diabetes on renal IGF/IGFBP system during neonatal period in the rat Am J Physiol Renal Physiol, December 1, 2000; 279(6): F1067 - F1076. [Abstract] [Full Text] [PDF]

				J. HAYLOR, H. HICKLING, E. EL ETER, A. MOIR, S. OLDROYD, C. HARDISTY, and A. M. EL NAHAS JB3, an IGF-I Receptor Antagonist, Inhibits Early Renal Growth in Diabetic and Uninephrectomized Rats J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2027 - 2035. [Abstract] [Full Text]

				M. Shinada, A. Akdeniz, S. Panagiotopoulos, G. Jerums, and L. A. Bach Proteolysis of Insulin-Like Growth Factor-Binding Protein-3 Is Increased in Urine from Patients with Diabetic Nephropathy J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1163 - 1169. [Abstract] [Full Text]

				G. Maor and E. Karnieli The Insulin-Sensitive Glucose Transporter (GLUT4) Is Involved in Early Bone Growth in Control and Diabetic Mice, But Is Regulated through the Insulin-Like Growth Factor I Receptor Endocrinology, April 1, 1999; 140(4): 1841 - 1851. [Abstract] [Full Text]

				M. J. Horney, D. W. Shirley, D. T. Kurtz, and S. A. Rosenzweig Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1045 - F1053. [Abstract] [Full Text] [PDF]

				J. A. M. J. L. Janssen, M. L. Jacobs, F. H. M. Derkx, R. F. A. Weber, A. J. van der Lely, and S. W. J. Lamberts Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 (IGFBP-1), and IGFBP-3 and Their Relationships to the Presence of Diabetic Retinopathy and Glomerular Hyperfiltration in Insulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2809 - 2815. [Abstract] [Full Text] [PDF]

				C. Hernandez-Sanchez, H. Werner, C. T. Roberts Jr., E. J. Woo, D. W. Hum, S. M. Rosenthal, and D. LeRoith Differential Regulation of Insulin-like Growth Factor-I (IGF-I) Receptor Gene Expression by IGF-I and Basic Fibroblastic Growth Factor J. Biol. Chem., February 21, 1997; 272(8): 4663 - 4670. [Abstract] [Full Text] [PDF]